On this page, you can find the information that we believe is both interesting and relevant to existing and potential investors in Audientes.
It includes company announcements, press releases, and our financial calendar, to ensure that you don’t miss out on any important news regarding the Audientes share.
Join us on our journey to make smart, self-fitting and affordable hearing aids available to the millions of people around the world suffering from disabling hearing loss.
Watch the video to learn more.
Be the first to read all about it
Sign up for the Audientes Quarterly Newsletter
Investor webinar with Audientes and Aktiesparende Sverige
Watch Audientes CEO, Steen Thygesen outline the Audientes share and our mission to make smart, self-fitting and affordable hearing aids accessible to the millions of people around the world who suffer from disabling hearing loss.
Audientes at the 2020 Small Cap Seminar
Watch our CEO, Steen Thygesen give a talk at the 2020 Small Cap Seminar, Audientes and our mission to bring smart, affordable and high-quality hearing aids to the millions of people around the world suffering from disabling hearing loss.
Steen has a bachelor degree in Electronics Engineering from Copenhagen’s Teknikum, and an MBA from London Business School. Throughout his 30-year career, both abroad and in Denmark, he has held positions at Star, Nokia Denmark A/S, Microsoft Inc., Symbian PLC, Psion Software PLC, CompuServe Inc. and TDC. He was also the Managing Director of Specialisterne Foundation, owner of the social economic enterprise, Specialisterne, where he led the establishment and growth of Specialisterne in 15 countries.
Hossein has an MA in Electric Engineering from Danmark’s Tekniske University. He began his career in Nokia in 1997 as a software engineer and held a number of roles, including Test Manager. In 2012, he founded the hearing aid research and development company, Jelveh Medical Device. In 2014, he founded Audientes.
Board of directors
Povl-André has a Masters of Science from CBS, and a long career in the life sciences industry, where he held several commercial and financial leadership positions. He holds a number of board positions, including Chairman of the Board for 2cureX AB, which is listed on the Nasdaq First North Sweden exchange.
Gitte has a degree in market economies and has more than 20 years of leadership experience within life sciences industries and has worked with strategic and commercial business development. She has held positions that include CFO, COO as well as Supply Chain Manager in pharmaceutical companies, Meda and Mylan. In connection with these, she has participated in several international M&A transactions. She currently holds the CEO position at UV Clinical.
Elsebeth has a university degree in Economics and has held numerous international positions within the life sciences industry, including international manager in GN Danavox A/S (now GN Resound), Director at Coloplast A/S as well as CEO of Danish Health Consult A/S. Additionally, she has been the Dean of the Bioanalyst Faculty in Copenhagen and Mentor at DTU Science Park, DeepTech mentoring since 2014.
Financial and legal documents
|October 22, 2020||Q3 2020 reporting|
|March 18, 2021||Q4 and Annual Report 2020|
|April 13, 2021||Annual General Meeting 2021|
|May 20, 2021||Q1 2021 reporting|
|August 19, 2021||Q2 2021 reporting|
|November 18, 2021||Q3 2021 reporting|